Qinghai Biotech Pharmaceutical Group Limited

Research Qinghai Biotech Pharmaceutical Group Limited (0876.HK) on Bullrun: market cap HKD 158.04M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker0876.HK
ExchangeHK
CountryHong Kong
SectorHealthcare
IndustryMedical Instruments & Supplies
CurrencyHKD
Market capHKD 158.04M
Financial periodFY2025
RevenueHKD 139.11M
Revenue growth-24.9%
Net income-HKD 46.68M
Free cash flow-HKD 58.41M
Gross margin36.4%

Valuation Snapshot

latest market cap is HKD 158.04M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	HKD 139.11M	-HKD 46.68M	-HKD 58.41M	36.4%	-0.01	HKD 109.60M	HKD 13.46M	HKD 403.38M
FY2024	HKD 185.36M	-HKD 46.36M	-HKD 39.08M	44.2%	-0.46	HKD 149.61M	HKD 10.65M	HKD 431.15M
FY2023	HKD 185.88M	HKD 7.47M	-HKD 46.70M	43.6%	0.08	HKD 174.08M	HKD 18.00M	HKD 492.01M
FY2022	HKD 191.50M	-HKD 123.32M	-HKD 72.58M	43.1%	-1.23	HKD 173.45M	HKD 31.87M	HKD 485.33M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	HKD 158.04M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About Qinghai Biotech Pharmaceutical Group Limited

Qinghai Biotech Pharmaceutical Group Limited, an investment holding company, engages in the health care and dental business in the People's Republic of China and internationally.

Related stock research

Hong Kong stocks Hong Kong Healthcare stocks A-Z stock index

Other Healthcare stocks

AMCO United Holding Limited (0630.HK) Arts Optical International Holdings Limited (1120.HK) Kelfred Holdings Limited (1134.HK) OrbusNeich Medical Group Holdings Limited (6929.HK) Pak Fah Yeow International Limited (0239.HK) Alibaba Health Information Technology Limited (0241.HK) China Healthwise Holdings Limited (0348.HK) Tian An Medicare Limited (0383.HK) Wanjia Group Holdings Limited (0401.HK) Hony Media Group (0419.HK) Tianda Pharmaceuticals Limited (0455.HK) Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK)

Frequently asked questions

What is Qinghai Biotech Pharmaceutical Group Limited's market cap?

Qinghai Biotech Pharmaceutical Group Limited's market capitalization is HKD 158.04M.

What does Qinghai Biotech Pharmaceutical Group Limited do?

Qinghai Biotech Pharmaceutical Group Limited, an investment holding company, engages in the health care and dental business in the People's Republic of China and internationally. It produces and sells dental prosthetics, including crowns and bridges, removable full and partial dentures, implants, and full-cast restorations, as well as provides sport rehabilitation services comprising postoperative rehabilitation, sports injury rehabilitation, chronic pain, scoliosis, deformity correction, and other rehabilitation services; and health leisure services.